香连丸联合5-氟尿嘧啶经p38 MAPK/NF-κB通路增强胃癌抗肿瘤活性并减轻胃肠道毒性
该研究在胃癌小鼠模型中口服香连丸并腹腔注射5-氟尿嘧啶,连续监测腹泻与移植瘤生长,2周后检测血清白介素-6及胃肠道和移植瘤组织的病理、凋亡与p38 MAPK表达。结果显示香连丸可减轻5-FU所致胃肠道黏膜损伤和腹泻,促进5-FU诱导的胃癌细胞凋亡并增强对移植瘤的抑制,其作用与调控p38 MAPK/NF-κB通路相关。
要点
- 香连丸联合5-FU可减轻5-FU所致胃肠道黏膜损伤和腹泻。
- 香连丸可促进5-FU诱导的胃癌细胞凋亡并增强抑瘤效果。
- 上述效应与调控p38 MAPK/NF-κB通路相关。
核心结论
- 香连丸联合5-FU可减轻5-FU的胃肠道副作用并增强对移植瘤的抑制作用。
- 这些效应与调控p38 MAPK/NF-κB通路有关。
研究设计与样本
- 在胃癌小鼠模型中口服香连丸并腹腔注射5-FU。
- 连续监测小鼠腹泻与移植瘤生长,2周后处死并收集血清。
- 检测血清白介素-6水平,并用Western blot分析胃肠道组织与移植瘤组织的病理变化、促炎因子及p38 MAPK表达。
主要发现
- 香连丸可减轻5-FU引起的胃肠道黏膜损伤并缓解腹泻。
- 香连丸可抑制核因子κB和髓样分化初级反应蛋白88的表达。
- 香连丸可促进5-FU诱导的胃癌细胞凋亡并增强5-FU对移植瘤的抑制作用。
- 香连丸给药可调控p38 MAPK的表达。
临床怎么用
- 在胃癌5-FU化疗期间可考虑联合香连丸以减轻胃肠道毒性并可能增强疗效。
- 联合应用时需关注p38 MAPK/NF-κB通路相关效应,但具体方案应结合临床辨证。
局限性
- 研究为胃癌小鼠模型,结果外推至人体需进一步临床验证。
- 原文摘要未报告样本量、具体剂量及统计学数值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
ETHNOPHARMACOLOGICAL RELEVANCE: Perioperative or postoperative adjuvant chemotherapy based on 5-fluorouracil (5-FU) is a common first-line adjuvant therapy for gastric cancer (GC). However, drug resistance and the side effects of 5-FU have reduced its efficacy. Among these side effects, gastrointestinal (GI) toxicity is one of the most common. Xianglian Pill (XLP) is a Chinese patent medicine that is commonly used for the treatment of diarrhoea. It can reduce inflammation and has a protective effect on the intestinal mucosa. Recent studies have shown that many components of XLP can inhibite tumor cell growth. However, the therapeutic effect of XLP in combination with 5-FU on GC is unclear. AIM OF THE STUDY: To investigate whether the combination of XLP and 5-FU can enhance anti-GC activity while reducing GI toxicity. MATERIALS AND METHODS: XLP was administered orally during intraperitoneal injection of 5-FU in GC mice model. Mice were continuously monitored for diarrhea and xenograft tumor growth. After 2 weeks, the mice were sacrificed and serum was collected to determine interleukin-6 levels. Pathological changes, the expression of pro-inflammatory factors and p38 mitogen-activated protein kinase (MAPK) in GI tissue were determined by Western blot analysis. Pathological changes, apoptosis levels and p38 MAPK expression levels in xenograft tissues were also determined. RESULTS: The results showed that XLP could alleviate GI mucosal injury caused by 5-FU, alleviated diarrhea, and inhibited the expression of nuclear factor (NF)-κB and myeloid differentiation primary response-88. Besides, XLP could promote the 5-FU-induced apoptosis of GC cells and enhance the inhibitory effect of 5-FU on tumor xenografts. Further study showed that XLP administration could regulate the expression of p38 MAPK. CONCLUSIONS: XLP in combination with 5-FU could alleviate its GI side effects and enhance its inhibitory effect on xenograft tumor. Moreover, these effects were found to be related to the regulation of the p38 MAPK/NF-κB pathway.
引用
- Yu L, Qin JY, Sun C, et al. Xianglian Pill combined with 5-fluorouracil enhances antitumor activity and reduces gastrointestinal toxicity in gastric cancer by regulating the p38 MAPK/NF-κB signaling pathway. J Ethnopharmacol. 2024. PMID: 38428657. doi:10.1016/j.jep.2024.117988
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。